Rosanne Lane

1125 Trenton-Harbourton Road,
Titusville, NJ
USA

Papers:
5.59 A Two-Year, Safety Evaluation of Paliperidone Extended-Release in the Treatment of Adolescents (12-17 Years) with Schizophrenia: An Open-Label, Flexible-Dose Study 5.60 Efficacy and Safety of Paliperidone Extended-Release in Adolescents with Schizophrenia: A Randomized, Multicenter, Double-Blind, Active-Controlled, Flexible-Dose, Parallel-Group Study

Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.